SCHEMBL7804382

SCHEMBL7804382

O=C(O)CCOc1ccccc1C1CCN(C(=O)c2ccccc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
PTGDR2 Q9Y5Y4 2/20 0.49
ACHE P22303 2/20 0.48
EPHX1 P07099 1/20 0.45
L3MBTL3 Q96JM7 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 1/20 0.45
KCNA5 P22460 1/20 0.44
HSD11B1 P28845 1/20 0.44
BACE1 P56817 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811675 0.92 KMT2A (0.58) MEN1KMT2APTGDR2L3MBTL3L3MBTL1
SCHEMBL7804407 0.88 NPC1 (0.53) MEN1KMT2APTGDR2L3MBTL3L3MBTL1
SCHEMBL7804447 0.83 ALDH1A1 (0.48) MEN1KMT2ALMNA
SCHEMBL7804397 0.82 NPC1 (0.52) MEN1KMT2APTGDR2LMNA
SCHEMBL7804406 0.81 S1PR1 (0.57) MEN1KMT2AACHEKCNA5HSD11B1
SCHEMBL7814370 0.79 CNR2 (0.50) MEN1KMT2ALMNA
SCHEMBL7811526 0.78 PARP10 (0.53) MEN1KMT2AACHELMNAKCNA5
SCHEMBL22357441 0.78 SSTR1 (0.53) MEN1KMT2APTGDR2LMNA
SCHEMBL7817555 0.78 SMN1; SMN2 (0.61) MEN1KMT2ALMNAKCNA5
SCHEMBL7813945 0.76 PTGDR2 (0.56) MEN1KMT2APTGDR2L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed